pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 18·1 min read
save

STAT invites reader letters on primary care value, obesity as disease and broader health-care debates

Jul 18, 2026·read at STAT ↗Neutral

STAT’s First Opinion platform encourages readers to submit letters responding to its essays, fostering open, good‑faith discussion about health‑care topics.

Recent letters, echoing comments from the presidents of the AAFP, ACP and AAP, argue that the debate should move beyond narratives that pit primary care against specialty care.

Contributors stress that patients need both types of care – for example, a person with diabetes relies on a trusted primary‑care physician for ongoing management and on specialists when complications arise, while children benefit from pediatric monitoring and specialist referral when needed.

The editors invite continued submissions, noting that such letters help shape dialogue on issues ranging from primary‑care access to recognizing obesity as a disease.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: STAT readers on the value of primary care, obesity as a disease, and more”

read at STAT ↗
3,613 words · retrieved Jul 18
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING3AMICUS THERAPEUTICS, INC.Ultragenyx Pharmaceutical Inc.
drugs
Obesity27
topics
Obesity32Cardiology12Type 2 Diabetes7Alzheimer's Disease2GLP-1 receptor2Hematology2Oncology2Endocrinology & MetabolismHeart FailureHypertensionNephrologyPainPsychiatry & CNSRare Disease

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 5h agoTScan axes 75% of workforce, prioritizes solid tumor programBioSpace
  • Jul 1Statins and blood pressure drugs changing health risks of obesity, study suggestsSTAT
  • Dec 22Fierce Biotech Fundraising Tracker '26: Superluminal snags $60M; AusperBio adds $120MFierce Biotech
  • Jul 28After PCOS became PMOS, there’s hope for new awareness among Black and Latina womenSTAT